Celldex Therapeutics Statistics
NASDAQ: CLDXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
27.42-0.54 (-1.93%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Celldex Therapeutics by the numbers
Celldex Therapeutics has a market capitalization of $2.15 billion based on 78.55M shares outstanding. With trailing EPS of $-4.29, Celldex Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.3% below its 50-day average and 16.7% below its 200-day average.
Average daily trading volume is 1.33M shares, or about $36.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CLDX valuation vs. peer median
| Metric | CLDX | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.15B | $547.30M | +294% |
| Avg. volume | 1.33M | 1.71M | -22% |
Peer median across 8 companies: NEOG, NTLA, QUIT, QDEL, MYGN, TKNO, NNNN, ICCC.
Valuation
- Market cap
- $2.15B
- Price / sales (latest FY)
- 1,393.98
- EPS (TTM)
- $-4.29
- Shares outstanding
- 78.55M
Price and trading
- Previous close
- 27.96
- Open
- 27.05
- Day range
- 26.64 – 28.43
- 52-week range
- 22.33 – 45.14
- 52-week change
- +5.79%
- Beta
- —
- Volume
- 1.72M
- Average volume
- 1.33M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 2.15B
- Forward Pe
- -6.57
- Eps
- -4.29
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 45.14
- Week52 Low
- 22.33
- Avg Volume
- 1.33M
- Shares Outstanding
- 78.55M
- Ma50
- 30.92
- Ma200
- 32.93
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -39.26%
- Pct From52w Low
- 22.79%